AbstractTreatment-resistant depression is a difficult problem in clinical practice. Evidence for the efficacy of newer antidepressants, such as duloxetine and bupropion, is not yet well established. We present a case of treatment-resistant depression with full recovery where a combination of mirtazapine and bupropion was used after a failed response to combined mirtazapine and duloxetine treatment
Objective: Venlafaxine and mirtazapine in combination are increasingly used in clinical practice to ...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Depression is an illness of modern society, which affects population of different age. Etiological f...
AbstractTreatment-resistant depression is a difficult problem in clinical practice. Evidence for the...
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reupta...
Objective: Despite the adequate time and dose of antidepressant treatment, approximately one-third o...
he efficacy, safety, and tolerability of combined bupropion versus placebo using duloxetine as activ...
Dual antidepressant combination for treatment-resistant depression is a strategy well supported by l...
Several acute depression trials suggest that only 35% of the patients achieve remission state with a...
Objective: Venlafaxine and mirtazapine in combination are increasingly used in clinical practice to ...
The concept of Resistant Depression was introduced for the first time in 1974 by Leiman. Despite the...
Introduction: Although a growing selection of antidepressants is available, a significant number of ...
Background: Depression is usually managed in primary care and antidepressants are often the first-li...
BACKGROUND: Depression is usually managed in primary care and antidepressants are often the first-li...
Although the lack of evidence in literature for the treatment of resistant depression has not been t...
Objective: Venlafaxine and mirtazapine in combination are increasingly used in clinical practice to ...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Depression is an illness of modern society, which affects population of different age. Etiological f...
AbstractTreatment-resistant depression is a difficult problem in clinical practice. Evidence for the...
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reupta...
Objective: Despite the adequate time and dose of antidepressant treatment, approximately one-third o...
he efficacy, safety, and tolerability of combined bupropion versus placebo using duloxetine as activ...
Dual antidepressant combination for treatment-resistant depression is a strategy well supported by l...
Several acute depression trials suggest that only 35% of the patients achieve remission state with a...
Objective: Venlafaxine and mirtazapine in combination are increasingly used in clinical practice to ...
The concept of Resistant Depression was introduced for the first time in 1974 by Leiman. Despite the...
Introduction: Although a growing selection of antidepressants is available, a significant number of ...
Background: Depression is usually managed in primary care and antidepressants are often the first-li...
BACKGROUND: Depression is usually managed in primary care and antidepressants are often the first-li...
Although the lack of evidence in literature for the treatment of resistant depression has not been t...
Objective: Venlafaxine and mirtazapine in combination are increasingly used in clinical practice to ...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Depression is an illness of modern society, which affects population of different age. Etiological f...